Pediapharm Inc. (CVE:PDP – Get Free Report)’s stock price traded up 1.7% on Wednesday . The company traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87. The company’s fifty day moving average is C$0.30 and its 200 day moving average is C$0.30. The firm has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Recommended Stories
- Five stocks we like better than Pediapharm
- The Significance of Brokerage Rankings in Stock Selection
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What is a Special Dividend?
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What is a Stock Market Index and How Do You Use Them?
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
